Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06527521

Prevalence of Amyloidosis in Trauma Patients

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil

Sant Pere de Ribes, Barcelona, 08810, Spain

Location status: Recruiting

Location contact

Lidia Tikhomirova

CONTACT

[email protected]

+34 938960025

Lidia Tikhomirova, MD

PRINCIPAL_INVESTIGATOR

Noemí Casaponsa

CONTACT

[email protected]

+34 938960025 ext. 43197

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
  • Ability to cooperate in the necessary evaluations.
  • Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion criteria

  • Participants previously diagnosed with amyloidosis cannot be included in the study.

Treatment and study plan

Traumatologic surgery

Procedure

Patients undergoing trauma surgery

Primary outcomes

  1. Amyloidosis

    Time frame: One month

    Proportion of patients undergoing scheduled orthopedic surgery who are diagnosed with amyloidosis.

Study contacts

Contact information is provided by the study sponsor or research team.

Lidia Tikhomirova, MD

CONTACT

[email protected]

+34 938960025

Noemí Casaponsa

CONTACT

[email protected]

+34 938960025 ext. 43197

Sponsors and collaborators

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Other

Registry information

Official study title

Prevalence of Amyloidosis in Trauma Patients Using Red Flags Tool

Acronym: APTUR

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jul 30, 2024
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.